Subscribe to out newsletter today to receive latest news administrate cost effective for tactical data.

D-471 (Fourth Floor), Above Wholesale Market, Gala Gymkhana Road, South Bopal, Bopal, Ahmedabad, Gujarat-380058

info@qxpts.com

+91 99798 42207/ +91 99798 94611

Let’s Stay In Touch

Shopping cart

Subtotal $0.00

View cartCheckout

    Download

    Data Integrity

    Curved Image

    • QxP Pharma Consultants – Your Partner in Data Integrity Risk Assessment and Remediation

    • QxP Pharma Consultants & GMP Services is a leading name in ensuring Pharmaceutical Data Integrity Compliance across India.
    • As a trusted partner to pharmaceutical, biotechnology, and life sciences companies, we specialize in implementing robust Data Integrity in GMP Environments that align with global regulatory expectations.
    • With deep domain expertise, particularly in GMP Services Providing in India and pan-India coverage, QxP delivers end-to-end support to safeguard critical data across the product lifecycle.
    • In the current regulatory landscape, Data Integrity is no longer just a compliance checkbox—it’s a core element of quality management and patient safety.
    • Whether it’s 21 CFR Part 11 Data Integrity, WHO Data Integrity Guidelines, or ALCOA+ Principles in Pharma, our experts help you meet the evolving expectations of the US FDA, MHRA, EMA, WHO, and other regulatory authorities.

    • Why Data Integrity Matters in the Pharma Industry?

    • Data Integrity refers to the completeness, consistency, and accuracy of data throughout its lifecycle.
    • In regulated industries, especially pharmaceuticals, compromised data can lead to regulatory citations, product recalls, or worse—risk to patient safety.

    • Key Regulatory Drivers:

    • 21 CFR Part 11 Compliance
    • EU Annex 11
    • WHO Technical Report Series 1019
    • MHRA Data Integrity Guidance
    • PIC/S PE009
    • To maintain public trust and regulatory approval, companies must adopt structured Data Governance in Pharma, supported by validated systems and well-trained staff.

    • QxP Pharma Consultants: Experts in GxP Data Integrity Services

    • As a premium Pharma Consultant in India, QxP Pharma Consultants & GMP Services in Ahmedabad offers comprehensive GMP Data Integrity Audits, Data Integrity Gap Analysis, and Computerized System Data Integrity Validation for all GxP systems.
    • Our specialized GMP Services Providing in India include:
    • Data Integrity Risk Assessments
    • Audit Trail Review Compliance
    • Data Integrity in Laboratory Systems
    • Electronic Records and Signatures Compliance
    • Data Integrity Monitoring Solutions
    • We help clients align with ALCOA+ Principles (Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring, Available) and ensure data remains reliable across digital and manual systems.

    • Our Pharma Data Integrity Services


    • 1. GMP Data Integrity Audits

    • Our seasoned auditors conduct detailed on-site and remote GMP Data Integrity Audits, evaluating paper-based records, laboratory instruments, ERP systems, LIMS, and MES platforms. Audits are mapped to FDA and WHO expectations and focus on risk-based controls.
    • Audit Highlights:
    • Review of audit trails
    • Assessment of system controls and backups
    • User access controls and roles
    • Record retention and version control
    • Detection of data manipulation risks

    • 2. Data Integrity Gap Analysis

    • Identify weaknesses before regulatory agencies do. Our Data Integrity Gap Analysis benchmarks your systems and procedures against global best practices. We help pinpoint non-compliance and provide a tailored remediation roadmap.
    • Focus Areas:
    • Laboratory records and instruments
    • Production and batch records
    • Quality management systems
    • Electronic data storage systems

    • 3. Data Integrity Risk Assessment

    • QxP Pharma Consultants conducts comprehensive Data Integrity Risk Assessments to prioritize corrective actions. Our methodology is aligned with ICH Q9 risk management and considers:
    • Process criticality
    • Data lifecycle vulnerabilities
    • Human interaction and training gaps
    • Technical and procedural controls
    • This service is vital for firms seeking pre-inspection readiness or remediation following warning letters.

    • 4. Electronic Records and Signatures Compliance

    • We ensure your systems comply with 21 CFR Part 11 and Annex 11 requirements for electronic records and signatures. This includes:
    • Digital signature implementation
    • Role-based access control
    • System validation and audit trail retention
    • Electronic batch record (EBR) compliance

    • 5. Computerized System Data Integrity Validation

    • We specialize in validating GxP computerized systems used in manufacturing, QA, QC, clinical, and R&D environments. Leveraging GAMP 5 methodology, we ensure systems are:
    • Appropriately validated
    • Data secure and access-controlled
    • Equipped with comprehensive audit trails
    • Integrated with quality management workflows
    • This includes Ensuring Data Integrity in CSV (Computer System Validation) and integration with ERP/LIMS/MES platforms.

    • Data Integrity in Laboratory Systems

    • Modern analytical labs rely heavily on computerized instruments. QxP assists clients in maintaining Data Integrity in Laboratory Systems , covering:
    • Chromatography data systems (CDS)
    • Laboratory information management systems (LIMS)
    • Standalone analytical instruments
    • Validation of software and firmware updates
    • We offer detailed Audit Trail Review Compliance to meet FDA and MHRA scrutiny.

    • Regulatory Support for Data Integrity Remediation

    • Whether responding to an FDA 483 observation or a WHO deficiency, QxP’s team provides complete regulatory remediation and follow-up support, including:
    • CAPA development and implementation
    • Investigation of root causes
    • Interaction with global regulatory authorities
    • System updates and documentation control
    • We help you close regulatory gaps efficiently with sustainable solutions.

    • Why Choose QxP Pharma Consultants?

    • As a pioneer in GMP Services Providing in Ahmedabad and trusted partner across India, QxP brings a rare blend of:
    • 20+ years of GMP and data compliance experience
    • In-depth knowledge of US FDA, EMA, WHO, MHRA regulations
    • Tailored support for small, medium, and large enterprises
    • Turnkey data integrity solutions—from audit to validation
    • Ongoing support for regulatory filings, audits, and remediation
    • Our goal is to transform your data from a liability into a regulatory asset.

    • Frequently Asked Questions (FAQs)

    • Q1: What is data integrity in pharma manufacturing and why is it mandatory for GMP compliant plant operations in India?
    • Data integrity in pharma manufacturing ensures all records are complete, consistent, accurate, and trustworthy throughout the product lifecycle. In India, CDSCO, WHO-GMP, and Schedule M regulations mandate strict data integrity compliance across all manufacturing and quality systems. It follows ALCOA+ principles covering Attributable, Legible, Contemporaneous, Original, and Accurate data standards. Without robust data integrity systems, no pharma plant can sustain GMP compliance or pass CDSCO and WHO-GMP regulatory inspections successfully.

    • Q2: What are the key data integrity requirements for a GMP compliant pharma manufacturing plant in India?
    • Key data integrity requirements in India include implementation of ALCOA+ principles across all paper and electronic records. Facilities must maintain controlled audit trails, restricted access controls, validated computerized systems, and documented backup and recovery procedures. 21 CFR Part 11 and EU Annex 11 compliance is mandatory for all electronic records and electronic signatures. CDSCO and WHO-GMP inspectors audit every data integrity control during facility inspections. Gaps in any area trigger critical GMP deficiency observations and mandatory CAPA submissions.

    • Q3: How does a pharma plant implement and maintain data integrity compliance for CDSCO and WHO-GMP inspections in India?
    • Implementing data integrity compliance in Gujarat requires a structured approach. Start with a data integrity gap assessment across all systems. Develop a Data Integrity Policy and supporting SOPs. Validate all computerized systems following GAMP 5 methodology. Implement audit trail reviews and access control systems. Train all personnel on ALCOA+ principles. Maintain continuous data integrity monitoring through periodic reviews. Facilities with robust data integrity programs consistently pass CDSCO and WHO-GMP inspections with zero critical observations.

    • Q4: What are the most common data integrity failures that cause GMP inspection rejections for pharma plants in India?
    • Common data integrity failures in India include disabled audit trails, shared login credentials, backdated entries, and deleted electronic records. Uncontrolled spreadsheet use, missing access controls, and unvalidated SCADA or LIMS systems are equally frequent inspection triggers. CDSCO and WHO-GMP inspectors treat data integrity violations as the most critical GMP deficiency category. Such failures result in manufacturing suspensions, Import Alerts, Warning Letters, and complete loss of WHO-GMP export certifications for affected pharma facilities.

    • Q5: What documents are required for data integrity compliance during CDSCO and WHO-GMP regulatory inspections in India?
    • Mandatory data integrity documents for CDSCO and WHO-GMP inspections in India include Data Integrity Policy, ALCOA+ compliance procedures, audit trail review records, access control logs, computerized system validation reports, backup and recovery test records, electronic signature procedures, and periodic review reports. Data integrity risk assessments and CAPA records for previous violations are equally critical. All documents must demonstrate systematic data integrity governance across every paper and electronic record system in the pharma facility.

    • Q6: How does poor data integrity management impact pharma plant regulatory standing and export business in India?
    • Poor data integrity management severely damages pharma plant regulatory standing in India. CDSCO can suspend manufacturing licenses immediately upon discovering critical data integrity violations. WHO-GMP certification withdrawal blocks all export operations. USFDA issues Warning Letters and Import Alerts that permanently damage brand reputation in regulated markets. Recovery from a major data integrity failure takes 12 to 36 months and costs crores in remediation. Proactive data integrity management prevents all these catastrophic regulatory and business consequences effectively.

    • Q7: How does QXP Pharma Project Consultant & GMP Service Pvt. Ltd. help pharma plants achieve and maintain data integrity compliance in India?
    • QXP Pharma Project Consultant & GMP Service Pvt. Ltd. provides complete data integrity compliance services across India. Services include data integrity gap assessments, ALCOA+ policy development, SOP preparation, computerized system validation, audit trail implementation, access control design, and personnel training programs. Their team ensures full compliance with 21 CFR Part 11, EU Annex 11, WHO-GMP, and CDSCO requirements. Clients achieve robust data integrity governance systems that consistently withstand the most rigorous regulatory inspection scrutiny.

    • Partner With India’s Leading Pharma Data Integrity Consultants

    • If you’re looking to strengthen Pharmaceutical Data Integrity Compliance or prepare for your next regulatory audit, QxP Pharma Consultants & GMP Services is your ideal partner.
    • Whether you’re based in Gujarat or across India, our expertise in GMP Services Providing in Ahmedabad and nation-wide delivery ensures world-class compliance with a local touch.
    • Contact QxP Pharma Consultants in Ahmedabad today to learn how our Data Integrity in GMP Environment solutions can help secure your operations.